NCT02390518: Stereotactic Radiosurgery Dose Escalation for Brain Metastases

NCT02390518
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with leptomeningeal disease; Prior whole/partial brain irradiation or stereotactic radiosurgery; Brain lesions located in the brain stem or in other areas that can not receive SRS
https://ClinicalTrials.gov/show/NCT02390518

Comments are closed.

Up ↑